COSMCosmos Health Inc.

Nasdaq cosmosholdingsinc.com


$ 1.08 $ 0.01 (0.93 %)    

Friday, 06-Sep-2024 15:09:56 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 1.08
$ 1.08 x 100
-- x --
-- - --
$ 0.47 - $ 2.05
74,511
na
19.26M
$ 0.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cosmos-health-regains-full-compliance-with-nasdaq-listing-requirements

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated ...

Core News & Articles

Cosmos Health announced that it continues to hold the right to distribute mpox real-time PCR detection kits under its agreement...

 cosmos-healths-cana-laboratories-completes-facility-upgrades-and-secures-contract-manufacturing-agreement-with-provident-pharmaceuticals-for-432m-vials-of-de3-sole

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated ...

 cosmos-health-q2-eps-015-misses-014-estimate-sales-1321m-miss-1455m-estimate

Cosmos Health (NASDAQ:COSM) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.1...

 cosmos-healths-subsidiary-cana-laboratories-secures-additional-contract-manufacturing-agreements-with-provident-pharmaceuticals-provident-focuses-on-niche-and-legacy-pharmaceutical-products-and-medical-devices

Specifically, Cana secured additional orders to manufacture the following medicines:408,000 units of MIOREL, used to reduce and...

 cosmos-health-announces-successful-completion-of-pilot-production-and-scale-up-phases-of-ccx0722-a-biocompatible-hydrogel-for-weight-management

Global Weight Management Market Valued At $142.58B In 2022, Expected To Reach $298.66B By 2030 With 9.7% CAGR; Rising Obesity P...

 cosmos-healths-cana-secures-contract-manufacturing-agreement-with-australias-humacology-for-up-to-500000-cbd-units-annually

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated ...

 cosmos-health-signs-distribution-agreement-with-zendon-sro-in-slovakia-hungary-poland-and-czechia-for-its-sky-premium-life-nutraceutical-products-gains-access-to-more-than-6000-stores-of-pharmacy-and-retail-chains

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated ...

 why-cosmos-health-stock-is-trading-higher-friday

On Thursday afternoon, the global healthcare company announced it had signed an exclusive distribution agreement with Pharmalin...

 cosmos-health-enters-agreement-to-acquire-remaining-40-rights-to-wipo-filed-cns-cancer-drug-patent-strengthening-global-brain-tumor-market-position-financial-terms-of-transaction-not-disclosed

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION